Levesialle Diario

Ethinylestradiol and Levonorgestrel, the active ingredients in Levesialle Diario, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age.

GNH USA supplies Levesialle Diario as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levesialle Diario, a combined oral contraceptive, is used within the hormonal birth‑control family to prevent unintended pregnancy. - Contraception: prevents pregnancy by inhibiting ovulation and altering cervical mucus. - Family planning: provides a reliable hormonal method for women seeking birth control. - Pregnancy prevention: reduces the risk of unintended pregnancy when taken as prescribed.

Levesialle Diario may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort. - Spotting: irregular vaginal bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke: cerebrovascular accident due to clot or hemorrhage. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before using Levesialle Diario, consider the following precautions. - Smoking: avoid if you smoke more than 15 cigarettes per day, as risk of cardiovascular events increases. - Pregnancy: contraindicated; do not start if you are pregnant or suspect pregnancy. - History of thromboembolism: consult a healthcare professional if you have past blood‑clot events. - Liver disease: use with caution in patients with active liver disease. - Store at room temperature below 25°C: keep in the original pack, protect from moisture and direct sunlight.

Levesialle Diario can interact with other medicines.

Major Interactions (Avoid): - Rifampin (antibiotic): may reduce contraceptive effectiveness. - Carbamazepine (antiepileptic): may lower hormone levels and increase failure risk. - Efavirenz (antiretroviral): can diminish contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Ketoconazole (antifungal): may increase hormone concentrations, raising side‑effect risk. - St. John’s wort (herbal supplement): may decrease contraceptive effectiveness. - Diuretics: may affect blood pressure control while on hormonal therapy.